Fate Therapeutics Inc (NASDAQ:FATE)

5.20
Data as of Aug 19
 -0.27 / -4.94%
Today’s Change
4.30
Today|||52-Week Range
13.55
-17.20%
Year-to-Date
No recent news for Fate Therapeutics Inc.

Today’s Trading

Previous close5.47
Today’s open5.38
Day’s range-- - --
Volume8,600
Average volume (3 months)19,327
Market cap$106.9M
Dividend yield--
Data as of 08/19/2014

Growth & Valuation

Earnings growth (last year)-85.34%
Earnings growth (this year)+63.37%
Earnings growth (next 5 years)--
Revenue growth (last year)-63.63%
P/E ratioNM
Price/Sales38.13
Price/Book2.09

Competitors

 Today’s
change
Today’s
% change
STEMStemCells Inc-0.05-3.14%
ORPNBio Blast Pharma Ltd-0.09-1.21%
PIPPharmAthene Inc-0.05-2.37%
OXBTOxygen Biotherapeuti...-0.07-1.65%
Data as of 08/19/2014

Financials

Last reporting dateAugust 12, 2014
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$971.0K
Annual profit (last year)-$20.9M
Net profit margin-2,151.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Christian Weyer
COO, CFO, Secretary &
Treasurer
J. Scott Wolchko
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.